Category: Pharmaceuticals
Pharmaceuticals market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Inovio Pharmaceuticals Inc (INO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Inovio Pharmaceuticals Inc (INO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Inovio Pharmaceuticals Inc (INO:NAS). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Vertex Pharmaceuticals Incorporated (VRTX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Vertex Pharmaceuticals Incorporated (VRTX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Vertex Pharmaceuticals Incorporated (VRTX:NAS) ... Read More
-
Financial Analysis and Multi-Year Benchmarking: FitLife Brands Inc (FTLF:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: FitLife Brands Inc (FTLF:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: FitLife Brands Inc (FTLF:NAS). Includes Industry Averages & Top ... Read More
-
Financial Analysis and Multi-Year Benchmarking: ANI Pharmaceuticals Inc (ANIP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: ANI Pharmaceuticals Inc (ANIP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: ANI Pharmaceuticals Inc (ANIP:NAS). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Cumberland Pharmaceuticals Inc (CPIX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cumberland Pharmaceuticals Inc (CPIX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Cumberland Pharmaceuticals Inc (CPIX:NAS). Includes ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Alnylam Pharmaceuticals Inc (ALNY:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Alnylam Pharmaceuticals Inc (ALNY:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Alnylam Pharmaceuticals Inc (ALNY:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Catalyst Pharmaceutical Inc (CPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Catalyst Pharmaceutical Inc (CPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Catalyst Pharmaceutical Inc (CPRX:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: NovaBay Pharmaceuticals Inc (NBY:ASE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: NovaBay Pharmaceuticals Inc (NBY:ASE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: NovaBay Pharmaceuticals Inc (NBY:ASE). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Merck and Co Inc (MRK:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Merck and Co Inc (MRK:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Merck and Co Inc (MRK:NYS). Includes Industry Averages & Top Compe ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Lexicon Pharmaceuticals Inc (LXRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lexicon Pharmaceuticals Inc (LXRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Lexicon Pharmaceuticals Inc (LXRX:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: BioCryst Pharmaceuticals Inc (BCRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: BioCryst Pharmaceuticals Inc (BCRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: BioCryst Pharmaceuticals Inc (BCRX:NAS). Includes Ind ... Read More
-
Financial Analysis and Multi-Year Benchmarking: BioMarin Pharmaceutical Inc (BMRN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: BioMarin Pharmaceutical Inc (BMRN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: BioMarin Pharmaceutical Inc (BMRN:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Bio-Rad Laboratories Inc (BIO:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Bio-Rad Laboratories Inc (BIO:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Bio-Rad Laboratories Inc (BIO:NYS). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ligand Pharmaceuticals Incorporated (LGND:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Ligand Pharmaceuticals Incorporated (LGND:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Ligand Pharmaceuticals Incorporated (LGND:NAS) ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Amneal Pharmaceuticals Inc (AMRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Amneal Pharmaceuticals Inc (AMRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Amneal Pharmaceuticals Inc (AMRX:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ionis Pharmaceuticals Inc (IONS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Ionis Pharmaceuticals Inc (IONS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Ionis Pharmaceuticals Inc (IONS:NAS). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Abbott Laboratories (ABT:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Abbott Laboratories (ABT:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Abbott Laboratories (ABT:NYS). Includes Industry Averages & Top ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and fore ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save co ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save count ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless ho ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save coun ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts ... Read More
-
Revenue Forecasts to (2030) and Analytics for the Research and Development (R&D) in Engineering, Materials, Aerospace, Health, Pharma and Medical (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 541700
Revenue Forecasts to (2030) and Analytics for the Research and Development (R&D) in Engineering, Materials, Aerospace, Health, Pharma and Medical (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 541700 Vital industry - specific data including metrics, benchmarks, historic numbers, growth rates ... Read More
Research Assistance
